Chapter 1. BLOOD CANCER DRUGS MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. BLOOD CANCER DRUGS MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. BLOOD CANCER DRUGS MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. BLOOD CANCER DRUGS MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. BLOOD CANCER DRUGS MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. BLOOD CANCER DRUGS MARKET– By Blood Cancer Type

6.1. Leukemia

6.2. Lymphoma

Chapter 7. BLOOD CANCER DRUGS MARKET– By Treatment Approaches

7.1. Key Findings

7.2. Chemotherapeutic

7.3. mAbs/Targeted Therapies

7.4. Immunotherapeutic

Chapter 8. BLOOD CANCER DRUGS MARKET– By Drugs

8.1. Rituaxan/Mabthera (Rituximab)

8.2. Gleevac/Glivec (Imatinib)

8.3. Revlimid (Lenalidomide)

8.4. Velcade (Bortezomib)

8.5. Tasigna (Nilotinib)

8.6. Pomalyst (Pomalidomide)

8.7. Vidaza (Azacitidine)

8.8. Kyprolis (Carfilzomib)

8.9. Adcetris (Brentuximab Vedotin)

8.10. Other Drugs

Chapter 9. BLOOD CANCER DRUGS MARKET– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. BLOOD CANCER DRUGS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10

Download Sample